nference Completes $60M Series C to Accelerate and Expand Augmented Intelligence for Life Sciences
Focus includes biomedical data analytics to better understand novel coronavirus
Partnership with Mayo Clinic enhanced
Executive team and scientific and medical experts establish world-class organization to serve life sciences sector
CAMBRIDGE, Mass., Dec. 15, 2020 /PRNewswire/ nference, which synthesizes the world s biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC. nference - a science-first software company - continues to push the boundaries of augmented intelligence to accelerate the work of our expert scientists and technologists in making biomedical knowledge computable via our nferX